Error message

  • Failed to authorize with Brightcove
  • Failed to authorize with Brightcove
  • Failed to authorize with Brightcove
News | April 30, 2008

IntelliDOT Secures Second Patent for Medical Shorthand Bar-Codes

May 1, 2008 - IntelliDOT Corp. this week said it secured an additional patent covering its proprietary bar codes that can be scanned to enter shorthand medical notes as part of its bedside, hand-held CAREt medication administration system.

On April 29, the U.S. Patent and Trademark Office issued U.S. Patent No. 7,364,067 to IntelliDOT for its CAREt hospital management system. In addition to scanning traditional one and two-dimensional bar codes, the CAREt also scans IntelliDOT’s proprietary “DOT” symbols that are used as medical shorthand. By scanning a symbol, hospitals can create customized documentation and communication applications and nurses can complete documentation, communicate with others, and carry out tasks using a simple point-and-scan workflow model. IntelliDOT’s approach requires no typing on computer keyboards or navigating complicated screens on a PDA. The company said this facilitates quick, one-handed documentation at the bedside around customized operations and commands tailored to specific patient care needs and JCAHO requirements.

Built on a design that complements the way nurses work, the CAREt System provides a straightforward user interface that supports a comprehensive approach to medication safety and documentation at the bedside, the manufacturer said. Introduced in 2002, the CAREt device has been selected by numerous institutions, including 55 Health Management Associates (HMA) hospitals and New York-Presbyterian Hospital. The company said the system can help significantly reduce medication errors.

For more information: www.intellidotcorp.com

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init